There are no upcoming webinars at this time, please check back soon.

SMA-MAP: A multiplexed immunoassay biomarker panel for Spinal Muscular Atrophy

Learn about an approach used for developing biomarkers in rare, pediatric disease and gain insights on current and future utility of the SMA-MAP panel in SMA and other neuromuscular research.
Request Recorded Webinar

Translating Preclinical Pharmacology in Clinical Activity

Attend to learn how Myriad RBM’s products and services were used by VentiRx to compare potency, define PK/PD relationships, identify potential clinical biomarkers of VTX-2337 activity and establish a Minimal Anticipated Biological Effect Level (MABEL) for the initial clinical trial.
View Recorded Webinar

Drug Induced Kidney Injury Biomarkers: Data From Four Species

Translatability and Utility in Drug Safety Studies and Kidney Disease Research – Find out how this suite of solutions, developed in conjunction with the Predictive Safety Testing Consortium (PSTC), can help you expedite translational development from pre-clinical animal studies to early clinical testing.
View Recorded Webinar

How to Implement a Sound Biomarker Strategy to Increase Your Success Rate in Drug Development.

Learn how Myriad RBM’s Strategic Biomarker Services can save time and money or even resurrect a late-stage failure. Recorded webinar coming soon.

Kidney MAPs^®: Biomarker Panels for Detecting Kidney Injury

Get the low-down on a recent set of publications by the Predictive Safety Testing Consortium (PSTC) on qualifying a panel of biomarkers for preclinical studies of nephrotoxicity using RBM’s Rat Kidney® MAP. Also, see data demonstrating the utility of the biomarkers for human kidney injury.
View Recorded Webinar

TruCulture^®: Simplicity in Ex Vivo Immune Monitoring

Discover what TruCulture is and how it’s helping drug developers make better decisions.
View Recorded Webinar